Latest round: Series A. Jianjun Li is a Co-founder of Darwin Cell Biology, an original biotechnology company established in June 2016.
Jianjun Li is a Co-founder of Darwin Cell Biology, an original biotechnology company established in June 2016. The company focuses on innovative drug R&D for neurological diseases, utilizing an MSC-derived protein complex platform. Darwin Cell Biology prioritizes conditions like ALS and stroke and is committed to advancing the clinical translation and industrialization of cell-free therapeutic technologies. The company's team was initially established in 2012, and it completed its Series A financing in 2019.
Full founder directory · Investor directory · Company funding database · Fundraising library